scispace - formally typeset
C

Cristina Gil

Publications -  9
Citations -  175

Cristina Gil is an academic researcher. The author has contributed to research in topics: Cathinone & Medicine. The author has an hindex of 5, co-authored 7 publications receiving 147 citations.

Papers
More filters
Journal ArticleDOI

The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin

TL;DR: It is suggested that adulteration is a real threat not only at the street level, but also for users that buy substances in cryptomarkets, and suggest the need for harm reduction initiatives in this setting.
Journal ArticleDOI

Something New about Something Old: A 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis.

TL;DR: The number of samples submitted which contained tryptamines increased during the course of the study, with significant differences in client expectations vs. analysis results between the controlled and uncontrolled groups.
Journal ArticleDOI

Patterns of use and toxicity of new para‐halogenated substituted cathinones: 4‐CMC (clephedrone), 4‐CEC (4‐chloroethcatinone) and 4‐BMC (brephedrone)

TL;DR: Results of the analysis of clephedrone, 4‐chloroethcathinone,4‐CEC, and brephedrones on recreational drug markets and a systematic review of all the available information concerning these substances are presented.
Journal ArticleDOI

Reporting the novel synthetic cathinone 5-PPDI through its analytical characterization by mass spectrometry and nuclear magnetic resonance

TL;DR: In this article, the identification and characterization of the novel synthetic cathinone 5-PPDI found in a suspect drug sample were performed, where the suspect sample was analyzed by gas chromatography-mass spectrometry (GC-MS), Fourier-transformed infrared (FTIR) spectroscopy, ultra-high performance liquid chromatography high-resolution mass spectrometer (HRMS) and nuclear magnetic resonance (NMR) analyzes.
Journal ArticleDOI

Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)-3-methylbutanamide, in Spain.

TL;DR: The aim of the work reported here was the determination of the main compound present in a crystal sample from an anonymous Spanish consumer, and the structure of a new designer drug derivate was elucidated after an exhaustive analysis using various analytical techniques.